Beleodaq
NDC 72893-002, Belinostat, injection, powder, lyophilized, for solution, from Acrotech Biopharma Inc.
- Product NDC
- 72893-002
- Status
- Listed
- Labeler
- Acrotech Biopharma Inc
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA206256
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72893-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BELINOSTAT500 mg/10mL
Pharmacologic classes
Histone Deacetylase Inhibitor [EPC]; Histone Deacetylase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72893-002-01 | 72893000201 | 1 VIAL in 1 CARTON (72893-002-01) / 10 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2e8ef36b-71fa-4492-a16f-577d5f7d111dMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=72893-002
Use it
Look up 72893-002 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72893-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72893-002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.